Schroeder Theodore R
- SEC CIK
- 0001378690
No open-market purchases or sales filed in the past year.
Current role at each company
- PHAT Phathom Pharmaceuticals, Inc.Directoras of May 21, 2026
- CDTX Cidara Therapeutics, Inc.Directoras of Jan 7, 2026
- Nabriva Therapeutics plcDirectoras of Jan 31, 2023
- OTIC Otonomy, Inc.Directoras of Jun 23, 2022
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Schroeder Theodore R as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
Nabriva Therapeutics plc
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 29, 2021 (view filing) | Dec 28 | 1 day | Schroeder Theodore RChief Executive Officer | PPurchase | +100.0K | $0.57 | +$57.0K | +44.3%325.9K after | |
| Sep 15, 2021 (view filing) | Sep 14 | 1 day | Schroeder Theodore RChief Executive Officer | PPurchase | +50.0K | $1.13 | +$56.5K | +28.3%226.9K after |